The Readout Loud
A podcast by STAT - Thursdays
Categories:
324 Episodes
-
321: Summit's upcoming cancer results, Recursion's mixed data, and the next big obesity target
Published: 9/5/2024 -
320: Jim Wilson's next venture, a surprise startup shutdown, & Lilly's Zepbound strategy
Published: 8/29/2024 -
From "Say More": What Happens When AI Decides Your Medical Coverage
Published: 8/23/2024 -
319: BioMarin's executive shakeup, a GLP-1 lowers diabetes risk, and a deep look at Recursion's AI bona fides
Published: 8/22/2024 -
318: Drug pricing drops & psychedelics under fire
Published: 8/15/2024 -
317: VC struggles, drug pricing negotiations, & Novo's abrupt Wegovy decision
Published: 8/8/2024 -
316: The long journey to make malaria vaccines, and Sarepta's ties with patient advocates
Published: 8/1/2024 -
315: UnitedHealth's doctor empire, an FDA departure, and Viking's obesity moves
Published: 7/25/2024 -
314: JD Vance's biotech ties, Cassava resignations, and insulin shortages
Published: 7/18/2024 -
313: Biotech layoffs, founder-focused VC, & a big pharma exit
Published: 7/11/2024 -
312: Medicare coverage for GLP-1 drugs, AI, and health care at the presidential debate
Published: 6/27/2024 -
311: Fauci's memoir, Alnylam's tenuous trial, and a mid-year review
Published: 6/20/2024 -
310: Duchenne gene therapy setback, Alzheimer's drug endorsement & why a STAT reporter buys weed (for journalism)
Published: 6/13/2024 -
309: Psychedelics at the FDA, ASCO recap, & MorphoSys update
Published: 6/6/2024 -
308: An ASCO preview & another Duchenne trial failure
Published: 5/30/2024 -
307: More tumult at BIO & coercive care for sickle cell patients
Published: 5/23/2024 -
306: Live! From the STAT Breakthrough Summit West
Published: 5/16/2024 -
305: Everything you need to know about H5N1 bird flu
Published: 5/9/2024 -
304: Controversial brain tissue research, obesity drug sales and Novartis’ M&A drama
Published: 5/2/2024 -
303: A new obesity startup, an acquisition gone wrong, & the future of Teledoc
Published: 4/18/2024
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.